| Literature DB >> 19728889 |
Andrei Y Istomin1, Adam Godzik.
Abstract
BACKGROUND: TheEntities:
Mesh:
Substances:
Year: 2009 PMID: 19728889 PMCID: PMC2747839 DOI: 10.1186/1471-2172-10-48
Source DB: PubMed Journal: BMC Immunol ISSN: 1471-2172 Impact factor: 3.615
Figure 1Phylogeny of amino acid sequences of C-terminal LRR domains agrees with classification of innate immunity receptors according to their N-terminal effector domains. The most divergent sequence, NAIP, was used to root the tree. Branch lengths are proportional to relative evolutionary distances. Integer numbers indicate bootstrap values (obtained by sampling over 1000 tree realizations) assessing statistical validity of the tree topology.
Figure 2Surface features of LRR domains from NLRs (homology models) and TLRs (X-ray crystal structures). Columns with three-dimensional structures show different views and representations of LRR domains. First column: cartoon representation colored according to secondary structure. Second, fourth, and sixth columns: molecular surfaces colored according to electrostatic potential. Third, fifth, and seventh columns: molecular surfaces colored according to hydrophobicity.
Figure 3An example of mapping the RI amino acid sequence into structure and of RI surface partitioning. A, Mapping between an LRR sequence motif and the RI structure. RI sequence was searched for the conserved LRR pattern LaaLXL, and 16 LRRs were identified. The residue X (magenta) was then used as a reference to define residues belonging to the inner concave surface (yellow and magenta), N-terminal side (green), C-terminal side (blue), and outer convex surface (red). Mapping between a general LRR motif sequence and the structure of LRR #13 is shown by coloring. B, Full RI surface partitioned into four parts as described above.
Predicted numbers of N-linked consensus glycosylation sites (NxT, NxS) in TLR ectodomains for each of the four domain surfaces.
| TLR1 | 4 | 1 | 0 | 0 |
| TLR2 | 1 | 2 | 0 | 1 |
| TLR3 | 3 | 7 | 0 | 6 |
| TLR4 | 1 | 3 | 0 | 0 |
| TLR5 | 2 | 2 | 1 | 3 |
| TLR6 | 3 | 0 | 1 | 2 |
| TLR7 | 3 | 1 | 1 | 6 |
| TLR8 | 3 | 4 | 0 | 7 |
| TLR9 | 4 | 4 | 1 | 6 |
| TLR10 | 2 | 1 | 1 | 1 |
Figure 4Hierarchical clustering analysis of amino acid hydropathy distributions within LRR domains of NLRs and TLRs. Color matrix shows values for first four moments (m0,..., m3; cf. Equation 1) of the hydropathy distribution over four LRR domain surfaces: inner (concave), N-terminal side, C-terminal side, and outer (convex). Red coloring corresponds to positive values of the moments, black to zero, and green to negative values. The measure of similarity between sequences of moment values of LRR surfaces is the Spearman's rank-order correlation coefficient, r. The tree on the left is the result of hierarchical clustering of pairwise distances by the complete linkage method. Length of edges is proportional to distances, d, between sequences of moment values and is defined as d= 1 - r. Grouping of LRR domains into clusters indicates overall similarity of their hydrophobicity distributions.
Figure 5Hierarchical clustering analysis of amino acid charge distributions within LRR domains of NLRs and TLRs. All notations are the same as in Figure 4.
Summary of putative NLR ligands predicted to bind to their LRR domains, based on similarity of surface features between NLRs and TLRs with known agonists.
| NALP5, NALP8 | n/a | ||||
| NALP7, NALP8 | n/a | ||||
| NLRC3 | NOD3 | NALP3 | no prediction | ||
| NALP14 | n/a | ||||
| NLRC5 | NOD4 | NALP12, NALP13 | no prediction | ||
| NLRP1 | NALP1 | MDP | n/a | ||
| n/a | |||||
| Bacterial RNA, | n/a | ||||
| NLRP4 | NALP4 | NALP14 | no prediction | ||
| NLRP5 | NALP5 | NOD1, NALP8 | NOD1, NALP8 | small molecules | |
| NLRP6 | NALP6 | TLR3 | TLR3 | RNA/DNA | |
| NLRP7 | NALP7 | NOD2, NALP13 | NOD2, NALP3 | small molecules | |
| NLRP8 | NALP8 | NOD1, NOD2, NALP5 | NOD1, NOD2, NALP5 | small molecules | |
| NLRP9 | NALP9 | RI | RI | protein-like | |
| NLRP10 | NALP10 | no prediction | |||
| NLRP11 | NALP11 | TLR7 | TLR3, TLR7 | RNA | |
| NLRP12 | NALP12 | Antagonizes IRAK-1 | NOD4 | no prediction | |
| NLRP13 | NALP13 | NOD4, NALP7 | no prediction | ||
| NLRP14 | NALP14 | NALP4, IPAF | IPAF | flagellin | |
| NLRB1 | NAIP | RI | TLR8 | no prediction | |
| NLRX1 | NOD5 | no prediction | |||
| protein-like | |||||
| RI | Ribonuclease | NALP9, NAIP | NALP9 | n/a | |
| TLR1 | triacyl lipopeptide (in complex with TLR2) | n/a | |||
| TLR2 | triacyl-, diacyl-lipopeptides (in complex with TLR1, TLR6) | n/a | |||
| TLR3 | dsRNA | NALP6 | NALP6, NALP11 | n/a | |
| TLR4 | LPS-loaded MD2 | CIITA | n/a | ||
| n/a | |||||
| TLR6 | diacyl-lipopeptide (in complex with TLR2) | n/a | |||
| NALP11 | n/a | ||||
| NAIP | n/a | ||||
| TLR9 | Bacterial and viral CpG DNA motifs | n/a | |||
| TLR10 | no prediction |
Cases with correctly reproduced similarities are highlighted in bold. In the "putative ligands" column, cases with known ligands are denoted by "n/a", and cases where no prediction was made are marked accordingly.